(2S)-2-amino-3-[[(1R,3S,6S,7S,11S,12S)-12-[(3S,5S,6S)-6-[(3S,5S,6R)-2-[[(2S)-2-amino-2-carboxyethyl]sulfanylmethyl]-6-[(3S,5S,6R)-6-[(3S,5S,6R)-6-[(3S,4R)-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6,7,11-trihydroxy-14-(hydroxymethyl)-2,4,9,13-tetraoxatricyclo[8.4.0.03,8]tetradecan-5-yl]methylsulfanyl]propanoic acid

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2S)-2-amino-3-[[(1R,3S,6S,7S,11S,12S)-12-[(3S,5S,6S)-6-[(3S,5S,6R)-2-[[(2S)-2-amino-2-carboxyethyl]sulfanylmethyl]-6-[(3S,5S,6R)-6-[(3S,5S,6R)-6-[(3S,4R)-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6,7,11-trihydroxy-14-(hydroxymethyl)-2,4,9,13-tetraoxatricyclo[8.4.0.03,8]tetradecan-5-yl]methylsulfanyl]propanoic acid
• 化学式: C₄₈H₈₀N₂O₃₆S₂
• 分子量: 1325.3
• InChiKey: ODIVPWOZEJUKOX-PHRZSGAKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -19
• 重原子数：
  88
• 可旋转键数：
  25
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.96
• 拓扑面积：
  671
• 氢给体数：
  22
• 氢受体数：
  40

文献信息

• Cyclodextrin-Based Polymers for Therapeutic Delivery
  申请人：Cerulean Pharma Inc.

  公开号：US20140213504A1

  公开（公告）日：2014-07-31

  Described herein are CDP-therapeutic peptide conjugates, therapeutic delivery systems comprising CDP-therapeutic peptide conjugates, compositions comprising CDP-therapeutic peptide conjugates, dosage forms comprising CDP-therapeutic peptide conjugates, and kits comprising CDP-therapeutic peptide conjugates. Also disclosed are methods of using (e.g., to treat a disorder) the CDP-therapeutic peptide conjugates, therapeutic delivery systems comprising CDP-therapeutic peptide conjugates, compositions comprising CDP-therapeutic peptide conjugates, dosage forms comprising CDP-therapeutic peptide conjugates, and kits comprising CDP-therapeutic peptide conjugates.